Carmen Krug, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 300 Cheyenne Ct, Deforest, WI 53532 Phone: 608-516-3702 |
Valerie Sherwood Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6902 Parkside Cir, Deforest, WI 53532 Phone: 608-846-2101 |
Tara Dahlke, BS, MA, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 217 Pocahontas Ln, Deforest, WI 53532 Phone: 715-529-7736 |
Lily Dettle Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 311 Winn Ct, Deforest, WI 53532 Phone: 715-520-3634 |
Joyce Dong Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6902 Parkside Cir, Deforest, WI 53532 Phone: 608-846-2101 |
News Archive
Chelsea Therapeutics International, Ltd. announced that during a teleconference yesterday, the U.S. Food and Drug Administration requested that the company delay the initiation of its proposed Phase II clinical study of CH-4051 in rheumatoid arthritis and indicated that the agency is requesting additional detail from the preclinical studies previously submitted as part of the company's investigational new drug application.
COMBINING the experimental drug Avastin (bevacizumab) with the diabetes drug Metformin almost doubles its ability to reduce skin cancer growth, according to a study in Cancer Discovery.
The American Physical Therapy Association is pointing to a new study on low back pain in Medicare patients in its efforts to encourage the newly established Center for Medicare and Medicaid Innovation to promptly launch a demonstration project on direct access to physical therapist services that was recommended in the recent health reform law.
HHS Secretary Mike Leavitt announced today the award of $1.2 million to improve efforts to reduce obesity among African Americans through a new partnership with national African American organizations.
Prevention of weight gain with a restricted calorie diet sharply reduced the development of pancreatic lesions that lead to cancer in preclinical research reported today by researchers from The University of Texas at Austin and The University of Texas M. D. Anderson Cancer Center at the American Association for Cancer Research annual meeting.
› Verified 7 days ago